No targets available; showing actuals against baseline.
Carbon per million dollars of revenue. The legacy industry-standard reference (CDP, MSCI). Useful for cross-sector context, but distorted by margin — high-margin firms appear artificially efficient. Read alongside the operational and asset intensities for the full picture.
OpEx (operating expenditure) is the running cost of the business — staff, services, energy, materials. This shows how carbon-intensive operations are per million dollars of spend. Removes the margin distortion that revenue-based ratios introduce.
EVIC (Enterprise Value Including Cash) is the firm's total capital footprint — equity + debt + cash + minority interest. The EU's standard intensity measure (SFDR PAI 3) — answers: how much carbon does each million of capital deployed in this business produce?
PP&E (Property, Plant & Equipment) plus leased real-estate assets is the firm's physical infrastructure on the balance sheet. This shows the carbon intensity of that physical footprint — uses Scope 1+2+3 for consistency with the other headline intensities. Surfaces stranded-asset risk for asset-heavy firms.
How the firm describes its decarbonisation approach in its own words — alongside the headline numbers above. Self-reported, page-cited.
Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023 (up from 57% in 2022) and maintained this in 2024. The company commits to maintaining 100% renewable electricity in its manufacturing plants as part of its Scope 1 & 2 carbon neutrality ambition by 2030.
To achieve Scope 1 & 2 carbon neutrality in manufacturing plants by 2030, Galderma's plan includes the acquisition of high-quality carbon credits to compensate for residual emissions, alongside replacing carbon-intensive equipment (e.g., gas boilers) and maintaining 100% renewable electricity. The company does not distinguish removals from offsets explicitly.
Galderma reduced water withdrawal intensity by more than 10% year-over-year in 2024 (5.0 m3/ton bulk vs 5.6 in 2023) and reduced waste intensity by more than 10% YoY. All manufacturing plants send zero waste to landfill. Target: 20% reduction in both water and waste intensity by 2030 vs 2022 baseline.
Galderma is phasing specific capital expenditure to replace carbon-intensive equipment such as gas boilers across its four manufacturing plants in Alby-sur-Chéran, Baie-D'Urfé, Hortolândia and Uppsala. Individual decarbonization plans are tailored to each site's specificity and maturity.
In 2024, Galderma launched a top supplier engagement program covering the top 80-90 suppliers in the most carbon-intensive procurement categories. Phase 1 focused on primary data collection including detailed life cycle assessments for specific raw materials to improve Scope 3 calculation accuracy. Phase 2 included discussions to identify mutually beneficial GHG reduction initiatives.
Galderma's Clean Beauty Charter lists ingredients to avoid/not use as part of every new Dermatological Skincare product development cycle. In 2024, the charter started including environmental assessment of ingredients (biodegradability, carbon footprint) to inform Scope 3 reduction efforts.
In 2024, Galderma launched a broad-based Sustainable Packaging Initiative to identify all potential sustainable packaging solutions across the Dermatological Skincare portfolio. It prioritizes initiatives by impact and feasibility and considers resource availability such as post-consumer recycled (PCR) plastic. A multi-disciplinary team includes Operations, Procurement, R&D, Commercial and ESG.
No target available for this scope.
No target available for this scope.
We haven't fully researched Galderma yet.
Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.
We’ll only use your email to notify you about this request.